We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

744 hedge funds and large institutions have $16.6B invested in Teva Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 744 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.92% more ownership

Funds ownership: 0% → 44.92% (+45%)

11% more call options, than puts

Call options by funds: $268M | Put options by funds: $242M

Holders
744
Holders Change
+744
Holders Change %
–
% of All Funds
24.28%
Holding in Top 10
32
Holding in Top 10 Change
+32
Holding in Top 10 Change %
% of All Funds
1.04%
New
744
Increased
–
Reduced
–
Closed
–
Calls
$268M
Puts
$242M
Net Calls
+$25.9M
Net Calls Change
+$25.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SGAM
476
Steinberg Global Asset Management
Florida
$847K +$841K +21,601 New
M&T Bank
477
M&T Bank
New York
$837K +$832K +21,360 New
TL
478
Tirschwell & Loewy
New York
$833K +$828K +21,250 New
SIM
479
Sentry Investment Management
Wisconsin
$827K +$822K +21,100 New
RW
480
Rand Wealth
Maryland
$819K +$814K +20,895 New
KJHP
481
K.J. Harrison & Partners
Ontario, Canada
$819K +$814K +20,900 New
SM
482
Sabby Management
Florida
$813K +$808K +20,736 New
ACA
483
Anchor Capital Advisors
Massachusetts
$812K +$807K +20,724 New
B
484
Baird
Wisconsin
$804K +$798K +20,504 New
SWM
485
Segment Wealth Management
Texas
$803K +$798K +20,479 New
Twin Tree Management
486
Twin Tree Management
Texas
$798K +$793K +20,351 New
PP
487
Paloma Partners
Connecticut
$797K +$792K +20,342 New
V
488
Veritable
Delaware
$789K +$783K +20,118 New
MIG
489
Mariner Investment Group
New York
$784K +$779K +20,000 New
SFM
490
Systematic Financial Management
New Jersey
$782K +$778K +19,970 New
PSUF
491
People's United Financial
Connecticut
$773K +$768K +19,725 New
LTFS
492
Ladenburg Thalmann Financial Services
Florida
$770K +$765K +19,649 New
BHWM
493
Bar Harbor Wealth Management
New Hampshire
$769K +$764K +19,620 New
FNT
494
First National Trust
Pennsylvania
$768K +$762K +19,575 New
BFM
495
Boston Financial Management
Massachusetts
$764K +$759K +19,486 New
IB
496
Intrust Bank
Kansas
$761K +$756K +19,414 New
NAM
497
Needelman Asset Management
California
$756K +$751K +19,280 New
ANBTV
498
American National Bank & Trust (Virginia)
Virginia
$755K +$750K +19,250 New
WDA
499
Wendell David Associates
New Hampshire
$748K +$747K +19,175 New
BA
500
Boston Advisors
Massachusetts
$745K +$740K +19,000 New
18 19
20
21 22

TEVA Hedge Fund Activity: Q2 2013 in Review

744 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q2 2013, worth a combined $16.6B.

Buyers outnumbered sellers: 744 funds opened new TEVA positions and 0 closed out — a net gain of 744 holders — while 0 added to existing stakes and 0 trimmed.

  • 744 institutional investors held Teva Pharmaceuticals (TEVA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6B of Teva Pharmaceuticals stock for Q2 2013.
  • 744 funds opened new Teva Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +744 holders.

Based on aggregated 13F filings for Q2 2013.